21st German Allergy Congress (DAK)
Oct 1 - Oct 3, 2026
- Title: Oral Deucrictibant Immediate-release Capsule for On-demand Treatment of Hereditary Angioedema Attacks: Phase 3 RAPIDe-3 Trial Results
Presenter: Markus Magerl, M.D.
Format: E-Poster
Date, time: Friday, October 2, 2026, 5:15-6:30 p.m. CEST (11:15 a.m.-12:30 p.m. EDT) - Title: Long-term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Final Results of the CHAPTER-1 Open-label Extension Study
Presenter: Emel Aygören-Pürsün, M.D.
Format: E-Poster
Date, time: Friday, October 2, 2026, 5:15-6:30 p.m. CEST (11:15 a.m.-12:30 p.m. EDT)